Masterclass: How Can DTx Companies Enter the US Market Successfully?

Despite the rapid expansion of the digital therapeutics (DTx) market in the US, DTx companies are still facing challenges in establishing a foothold and making an impact in the digital health industry. The complex regulatory environment, fierce competition from traditional healthcare providers, and dynamic market landscape are just some of the hurdles that DTx companies must navigate to succeed in this market. Consequently, it is crucial for any DTx company looking to expand their offerings to have a solid understanding of the keys to success in the US market. By doing so, DTx companies can identify opportunities for growth and innovation, establish key partnerships, and differentiate themselves from competitors.

Join this masterclass with Jonas Duss (Co-Founder at Kaia Health) to  discuss the key challenges facing DTx companies seeking to enter the US market and provide actionable insights and strategies for navigating the complex regulatory environment, establishing partnerships, and gaining market share.

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.